Evidence of insufficient quality of reporting in patent landscapes in the life sciences

James Andrew Smith · Zeeshaan Arshad · Hannah S. Thomas · Andrew Jonathan Carr · David A. Brindley

23 citations0/0 files storedNature Biotechnology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Intellectual Property and Patents scientometrics and bibliometrics research Meta-analysis and systematic reviews

Abstract

Despite the importance of patent landscape analyses in the commercialization process for life science and healthcare technologies, the quality of reporting for patent landscapes published in academic journals is inadequate.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 23 citations exist upstream.

References

2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement 2007The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies 2009The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials 1995Empirical Evidence of Bias 1995Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials 2009Avoidable waste in the production and reporting of research evidence 2004Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials

Cited by

2020Improving transparency and reproducibility of patent landscapes: the Reporting Items for Patent Landscapes (RIPL) statement and other considerations 2022Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases 2022What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review 2018Synthetic Biology - Mapping the Patent Landscape

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.